Literature DB >> 30111544

Rev7 dimerization is important for assembly and function of the Rev1/Polζ translesion synthesis complex.

Alessandro A Rizzo1, Faye-Marie Vassel2, Nimrat Chatterjee2, Sanjay D'Souza2, Yunfeng Li1, Bing Hao1, Michael T Hemann2,3, Graham C Walker2, Dmitry M Korzhnev4.   

Abstract

The translesion synthesis (TLS) polymerases Polζ and Rev1 form a complex that enables replication of damaged DNA. The Rev7 subunit of Polζ, which is a multifaceted HORMA (Hop1, Rev7, Mad2) protein with roles in TLS, DNA repair, and cell-cycle control, facilitates assembly of this complex by binding Rev1 and the catalytic subunit of Polζ, Rev3. Rev7 interacts with Rev3 by a mechanism conserved among HORMA proteins, whereby an open-to-closed transition locks the ligand underneath the "safety belt" loop. Dimerization of HORMA proteins promotes binding and release of this ligand, as exemplified by the Rev7 homolog, Mad2. Here, we investigate the dimerization of Rev7 when bound to the two Rev7-binding motifs (RBMs) in Rev3 by combining in vitro analyses of Rev7 structure and interactions with a functional assay in a Rev7-/- cell line. We demonstrate that Rev7 uses the conventional HORMA dimerization interface both to form a homodimer when tethered by the two RBMs in Rev3 and to heterodimerize with other HORMA domains, Mad2 and p31comet Structurally, the Rev7 dimer can bind only one copy of Rev1, revealing an unexpected Rev1/Polζ architecture. In cells, mutation of the Rev7 dimer interface increases sensitivity to DNA damage. These results provide insights into the structure of the Rev1/Polζ TLS assembly and highlight the function of Rev7 homo- and heterodimerization.

Entities:  

Keywords:  DNA damage tolerance; HORMA domain proteins; protein structure; protein–protein interactions; translesion synthesis

Mesh:

Substances:

Year:  2018        PMID: 30111544      PMCID: PMC6126741          DOI: 10.1073/pnas.1801149115

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  68 in total

1.  Crystal structure of the tetrameric Mad1-Mad2 core complex: implications of a 'safety belt' binding mechanism for the spindle checkpoint.

Authors:  Lucia Sironi; Marina Mapelli; Stefan Knapp; Anna De Antoni; Kuan-Teh Jeang; Andrea Musacchio
Journal:  EMBO J       Date:  2002-05-15       Impact factor: 11.598

Review 2.  Cellular functions of DNA polymerase zeta and Rev1 protein.

Authors:  Christopher W Lawrence
Journal:  Adv Protein Chem       Date:  2004

Review 3.  Timing and spacing of ubiquitin-dependent DNA damage bypass.

Authors:  Helle D Ulrich
Journal:  FEBS Lett       Date:  2011-05-18       Impact factor: 4.124

4.  Structural basis of Rev1-mediated assembly of a quaternary vertebrate translesion polymerase complex consisting of Rev1, heterodimeric polymerase (Pol) ζ, and Pol κ.

Authors:  Jessica Wojtaszek; Chul-Jin Lee; Sanjay D'Souza; Brenda Minesinger; Hyungjin Kim; Alan D D'Andrea; Graham C Walker; Pei Zhou
Journal:  J Biol Chem       Date:  2012-08-02       Impact factor: 5.157

5.  NMRPipe: a multidimensional spectral processing system based on UNIX pipes.

Authors:  F Delaglio; S Grzesiek; G W Vuister; G Zhu; J Pfeifer; A Bax
Journal:  J Biomol NMR       Date:  1995-11       Impact factor: 2.835

6.  Complex formation of yeast Rev1 and Rev7 proteins: a novel role for the polymerase-associated domain.

Authors:  Narottam Acharya; Lajos Haracska; Robert E Johnson; Ildiko Unk; Satya Prakash; Louise Prakash
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

Review 7.  Causes and consequences of replication stress.

Authors:  Michelle K Zeman; Karlene A Cimprich
Journal:  Nat Cell Biol       Date:  2014-01       Impact factor: 28.824

8.  REV7 counteracts DNA double-strand break resection and affects PARP inhibition.

Authors:  J Ross Chapman; Inger Brandsma; Guotai Xu; Jingsong Yuan; Martin Mistrik; Peter Bouwman; Jirina Bartkova; Ewa Gogola; Daniël Warmerdam; Marco Barazas; Janneke E Jaspers; Kenji Watanabe; Mark Pieterse; Ariena Kersbergen; Wendy Sol; Patrick H N Celie; Philip C Schouten; Bram van den Broek; Ahmed Salman; Marja Nieuwland; Iris de Rink; Jorma de Ronde; Kees Jalink; Simon J Boulton; Junjie Chen; Dik C van Gent; Jiri Bartek; Jos Jonkers; Piet Borst; Sven Rottenberg
Journal:  Nature       Date:  2015-03-23       Impact factor: 49.962

9.  MAD2L2 controls DNA repair at telomeres and DNA breaks by inhibiting 5' end resection.

Authors:  Vera Boersma; Nathalie Moatti; Sandra Segura-Bayona; Marieke H Peuscher; Jaco van der Torre; Brigitte A Wevers; Alexandre Orthwein; Daniel Durocher; Jacqueline J L Jacobs
Journal:  Nature       Date:  2015-03-23       Impact factor: 49.962

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  24 in total

1.  REV7 has a dynamic adaptor region to accommodate small GTPase RAN/Shigella IpaB ligands, and its activity is regulated by the RanGTP/GDP switch.

Authors:  Xin Wang; Nomi Pernicone; Limor Pertz; Deping Hua; Tianqing Zhang; Tamar Listovsky; Wei Xie
Journal:  J Biol Chem       Date:  2019-09-04       Impact factor: 5.157

Review 2.  The Rev1-Polζ translesion synthesis mutasome: Structure, interactions and inhibition.

Authors:  Alessandro A Rizzo; Dmitry M Korzhnev
Journal:  Enzymes       Date:  2019-08-09

3.  TRIP13 regulates DNA repair pathway choice through REV7 conformational change.

Authors:  Connor S Clairmont; Prabha Sarangi; Karthikeyan Ponnienselvan; Lucas D Galli; Isabelle Csete; Lisa Moreau; Guillaume Adelmant; Dipanjan Chowdhury; Jarrod A Marto; Alan D D'Andrea
Journal:  Nat Cell Biol       Date:  2020-01-08       Impact factor: 28.824

4.  Structural basis for shieldin complex subunit 3-mediated recruitment of the checkpoint protein REV7 during DNA double-strand break repair.

Authors:  Yaxin Dai; Fan Zhang; Longge Wang; Shan Shan; Zihua Gong; Zheng Zhou
Journal:  J Biol Chem       Date:  2019-12-03       Impact factor: 5.157

Review 5.  REV7 directs DNA repair pathway choice.

Authors:  Connor S Clairmont; Alan D D'Andrea
Journal:  Trends Cell Biol       Date:  2021-06-16       Impact factor: 20.808

Review 6.  REV7: Jack of many trades.

Authors:  Inge de Krijger; Vera Boersma; Jacqueline J L Jacobs
Journal:  Trends Cell Biol       Date:  2021-05-04       Impact factor: 20.808

7.  Structure-Based Drug Design of Phenazopyridine Derivatives as Inhibitors of Rev1 Interactions in Translesion Synthesis.

Authors:  Kerry Silva McPherson; Angela M Zaino; Radha C Dash; Alessandro A Rizzo; Yunfeng Li; Bing Hao; Irina Bezsonova; M Kyle Hadden; Dmitry M Korzhnev
Journal:  ChemMedChem       Date:  2021-01-28       Impact factor: 3.466

8.  Stability and sub-cellular localization of DNA polymerase β is regulated by interactions with NQO1 and XRCC1 in response to oxidative stress.

Authors:  Qingming Fang; Joel Andrews; Nidhi Sharma; Anna Wilk; Jennifer Clark; Jana Slyskova; Christopher A Koczor; Hannes Lans; Aishwarya Prakash; Robert W Sobol
Journal:  Nucleic Acids Res       Date:  2019-07-09       Impact factor: 16.971

9.  Federating Structural Models and Data: Outcomes from A Workshop on Archiving Integrative Structures.

Authors:  Helen M Berman; Paul D Adams; Alexandre A Bonvin; Stephen K Burley; Bridget Carragher; Wah Chiu; Frank DiMaio; Thomas E Ferrin; Margaret J Gabanyi; Thomas D Goddard; Patrick R Griffin; Juergen Haas; Christian A Hanke; Jeffrey C Hoch; Gerhard Hummer; Genji Kurisu; Catherine L Lawson; Alexander Leitner; John L Markley; Jens Meiler; Gaetano T Montelione; George N Phillips; Thomas Prisner; Juri Rappsilber; David C Schriemer; Torsten Schwede; Claus A M Seidel; Timothy S Strutzenberg; Dmitri I Svergun; Emad Tajkhorshid; Jill Trewhella; Brinda Vallat; Sameer Velankar; Geerten W Vuister; Benjamin Webb; John D Westbrook; Kate L White; Andrej Sali
Journal:  Structure       Date:  2019-11-25       Impact factor: 5.006

Review 10.  Translesion synthesis inhibitors as a new class of cancer chemotherapeutics.

Authors:  Seema M Patel; Radha Charan Dash; M Kyle Hadden
Journal:  Expert Opin Investig Drugs       Date:  2020-12-03       Impact factor: 6.206

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.